These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20133482)

  • 1. Diagnostic application of the A(1c) assay in renal disease.
    Sharif A; Baboolal K
    J Am Soc Nephrol; 2010 Mar; 21(3):383-5. PubMed ID: 20133482
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosylated and carbamylated haemoglobin in uraemia.
    Smith WG; Holden M; Benton M; Brown CB
    Nephrol Dial Transplant; 1989; 4(2):96-100. PubMed ID: 2496361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Middle molecules--a marker of endogenous intoxication (a review of the literature)].
    Parfenkova GA; Cherniad'eva IF; Sitina VK
    Vrach Delo; 1987 Apr; (4):72-7. PubMed ID: 3303687
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting A1C in non-diabetic individuals: Review and meta-analysis.
    Cavagnolli G; Pimentel AL; Freitas PA; Gross JL; Camargo JL
    Clin Chim Acta; 2015 May; 445():107-14. PubMed ID: 25818244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights about uremia through its attenuation by dialysis.
    Maher JF
    Artif Organs; 1986 Aug; 10(4):306-12. PubMed ID: 3753257
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplant HbA1c and Glucose Metabolism Parameters in Predicting Posttransplant Diabetes Mellitus and Their Course in the First 6 Months After Living-Donor Renal Transplant.
    Rao N; Rathi M; Sharma A; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Exp Clin Transplant; 2018 Aug; 16(4):446-454. PubMed ID: 29251576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of uremia on erythropoietin activity.
    Mirand EA; Murphy GP
    J Surg Oncol; 1969; 1(2):181-92. PubMed ID: 5000206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic renal failure].
    Borisov VV; Shilov EM
    Urologiia; 2017 Apr; (1 Suppl 1):11-18. PubMed ID: 28406591
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of HbA(1c) for the diagnosis of diabetes.
    Bonora E
    Curr Diab Rep; 2011 Dec; 11(6):470-1. PubMed ID: 21927804
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between glycemic control and adverse outcomes in diabetic patients with CKD.
    Onuigbo MA
    Arch Intern Med; 2012 Apr; 172(7):596; discussion 596-7. PubMed ID: 22493472
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemic control and cardiorenal outcomes in patients with advanced chronic kidney disease: relative or absolute risks?: comment on "Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease".
    Goff DC
    Arch Intern Med; 2011 Nov; 171(21):1927-8. PubMed ID: 22123801
    [No Abstract]   [Full Text] [Related]  

  • 14. NGAL: a new missing link between inflammation and uremic anemia?
    Bolignano D; Coppolino G; Lombardi L; Buemi M
    Ren Fail; 2009; 31(7):622-3. PubMed ID: 19839863
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycated haemoglobin A(1c) (HbA(1c) ) in the diagnosis of diabetes mellitus: don't forget the performance of the HbA(1c) assay.
    Schindhelm RK; Lenters-Westra E; Slingerland RJ
    Diabet Med; 2010 Oct; 27(10):1214-5. PubMed ID: 20854391
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease.
    Agarwal R; Light RP
    Am J Nephrol; 2011; 34(1):32-41. PubMed ID: 21659737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy.
    Tsugawa Y; Takahashi O; Meigs JB; Davis RB; Imamura F; Fukui T; Taylor WC; Wee CC
    Diabetes; 2012 Dec; 61(12):3280-4. PubMed ID: 22891221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of diabetes mellitus with glycated hemoglobin in China, a long way to go.
    Ji LN; Cai XL
    Chin Med J (Engl); 2011 Nov; 124(22):3605-6. PubMed ID: 22340210
    [No Abstract]   [Full Text] [Related]  

  • 19. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
    Chikotas N; Gunderman A; Oman T
    J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus--practical implications.
    Colagiuri S
    Diabetes Res Clin Pract; 2011 Sep; 93(3):312-3. PubMed ID: 21820751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.